Long-term survival after vascular surgery: Specific influence of cardiac factors and implications for preoperative evaluation

被引:45
作者
Back, MR
Leo, F
Cuthbertson, D
Johnson, BL
Shames, ML
Bandyk, DF
机构
[1] Univ S Florida, Div Vasc & Endovasc Surg, Coll Med, Surg Serv,James A Haley Vet Hosp, Tampa, FL 33606 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Biostat Core, Tampa, FL USA
关键词
D O I
10.1016/j.jvs.2004.07.038
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objective: We sought to identify specific determinants of long-term cardiac events and survival in patients undergoing major arterial operations after preoperative cardiac risk stratification by American College of Cardiology/American Heart Association guidelines. A secondary goal was to define the potential long-term protective effect of previous coronary revascularization (coronary artery bypass grafting [CABG] or percutaneous coronary intervention [PCI]) in patients with vascular disease. Methods: Four hundred fifty-nine patients underwent risk stratification (high, intermediate, low) before 534 consecutive elective or urgent ( < 24 hours after presentation) open cerebrovascular, aortic, or lower limb reconstruction procedures between August 1996 and January 2000. Long-term follow-up (mean, 56 +/- 14 months) was possible in 97% of patients. The Kaplan-Meier method was used for survival data. Long-term prognostic variables were identified with the multivariate Cox proportional hazards model and contingency table analysis censoring early (<30 days) perioperative deaths. Results. While 5 -year survival was 72% for the overall cohort, cardiac causes accounted for only 24% of all deaths, and new cardiac events (myocardial infarction, congestive heart failure, arrhythmia, unstable angina, new coronary angiography, new CABG or PCI, cardiac death) affected only 4.6% of patients per year during follow-up. High cardiac risk stratification level (hazards ratio [HR], 2.2, 95% confidence interval [CI], 1.4-3.4), adverse perioperative cardiac events (myocardial infarction, congestive heart failure, ventricular arrhythmia; HR, 2.2; 95% CI, 1.2-4.1), and age (HF, 0.33; 95% C1, 0.2-0.6) were independently prognostic for late mortality. Preoperative cardiac risk levels also correlated with new cardiac event rates (P (.)<01) and late cardiac mortality (P =.02). Modestly improved survival in patients who had undergone CABG or PCI less than 5 years before vascular operations compared with those who had undergone revascularization 5 or more years previously and those at high risk without previous coronary intervention (73% vs 58% vs 62% 5-year survival; P =.02) could be demonstrated with univariate testing, but not with multivariate analysis. Type of operation, urgency, noncardiac complications, and presence of diabetes did not affect long-term survival. Conclusion: Despite cardiac events being a less common cause of late mortality after vascular surgery, perioperative cardiac factors (age, preoperative risk level, early cardiac complications) are the primary determinants of patient longevity. Patients undergoing more recent (<5 years) CABG or PCI before vascular surgery do not have an obvious survival advantage compared with patients at high cardiac risk without previous coronary interventions.
引用
收藏
页码:752 / 760
页数:9
相关论文
共 27 条
[1]   Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes [J].
Antman, EM ;
Tanasijevic, MJ ;
Thompson, B ;
Schactman, M ;
McCabe, CH ;
Cannon, CP ;
Fischer, GA ;
Fung, AY ;
Thompson, C ;
Wybenga, D ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (18) :1342-1349
[2]  
Back Martin R, 2003, Vasc Endovascular Surg, V37, P387, DOI 10.1177/153857440303700602
[3]   Limitations in the cardiac risk reduction provided by coronary revascularization prior to elective vascular surgery [J].
Back, MR ;
Stordahl, N ;
Cuthbertson, D ;
Johnson, BL ;
Bandyk, DF .
JOURNAL OF VASCULAR SURGERY, 2002, 36 (03) :526-533
[4]   Cardiac risk stratification for high-risk vascular surgery [J].
Bartels, C ;
Bechtel, JFM ;
Hossmann, V ;
Horsch, S .
CIRCULATION, 1997, 95 (11) :2473-2475
[5]   Dipyridamole-thallium/sestamibi before vascular surgery: A prospective blinded study in moderate-risk patients [J].
de Virgilio, C ;
Toosie, K ;
Ephraim, L ;
Elbassir, M ;
Donayre, C ;
Baker, JD ;
Narahara, K ;
Mishkin, F ;
Lewis, RJ ;
Chang, C ;
White, R ;
Mody, FV .
JOURNAL OF VASCULAR SURGERY, 2000, 32 (01) :77-86
[6]   Cardiac risk of noncardiac surgery - Influence of coronary disease and type of surgery in 3368 operations [J].
Eagle, KA ;
Rihal, CS ;
Mickel, MC ;
Holmes, DR ;
Foster, ED ;
Gersh, BJ .
CIRCULATION, 1997, 96 (06) :1882-1887
[7]   ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - Executive summary [J].
Eagle, KA ;
Berger, PB ;
Calkins, H ;
Chaitman, BR ;
Ewy, GA ;
Fleischmann, KE ;
Fleisher, LA ;
Froehlich, JB ;
Gusberg, RJ ;
Leppo, JA ;
Ryan, T ;
Schlant, RC ;
Winters, WL ;
Gibbons, RJ ;
Antman, EM ;
Alpert, JS ;
Faxon, DP ;
Fuster, V ;
Gregoratos, G ;
Jacobs, AK ;
Hiratzka, LF ;
Russell, RO ;
Smith, SC .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (03) :542-553
[8]   COMBINING CLINICAL AND THALLIUM DATA OPTIMIZES PREOPERATIVE ASSESSMENT OF CARDIAC RISK BEFORE MAJOR VASCULAR-SURGERY [J].
EAGLE, KA ;
COLEY, CM ;
NEWELL, JB ;
BREWSTER, DC ;
DARLING, RC ;
STRAUSS, HW ;
GUINEY, TE ;
BOUCHER, CA .
ANNALS OF INTERNAL MEDICINE, 1989, 110 (11) :859-866
[9]   Implementing ACC/AHA guidelines for the preoperative management of patients with coronary artery disease scheduled for noncardiac surgery: Effect on perioperative outcome [J].
Farid, I ;
Litaker, D ;
Tetzlaff, JE .
JOURNAL OF CLINICAL ANESTHESIA, 2002, 14 (02) :126-128
[10]   American College of Cardiology/American Heart Association preoperative assessment guidelines reduce resource utilization before aortic surgery [J].
Froehlich, JB ;
Karavite, D ;
Russman, PL ;
Erdem, N ;
Wise, C ;
Zelenock, G ;
Wakefield, T ;
Stanley, J ;
Eagle, KA .
JOURNAL OF VASCULAR SURGERY, 2002, 36 (04) :758-763